海外の治験の状況「1」での検索結果
860件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- A MULTICENTER, MULTINATIONAL, PROSPECTIVE, INTERVENTIONAL, SINGLE-ARM, PHASE IV STUDY EVALUATING THE CLINICAL EFFICACY AND SAFETY OF 26 WEEKS OF TREATMENT WITH INSULIN GLARGINE 300 U/ML (GLA-300) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS UNCONTROLLED ON BASAL INSULIN
- -E10 Insulin-dependent diabetes mellitus br>Insulin-dependent diabetes mellitus;E10 ;Insulin-dependent diabetes mellitus
- Arabia Saudi, Argentina, China, Colombia, Egypt, India, Indonesia, Lebano, Malasya, Peru, Philippines, South Africa, Thailand, Tunisia, Turkey
- 2019-06-26
Not Recruiting
- Study to compare the efficacy and/or safety of masitinib at 3 mg/kg/day with switch to 4.5 then to 6 mg/kg/day to interferon beta-1a, interferon beta-1b, peginterferon beta-1a or glatiramer acetate in patients with relapsing remitting multiple sclerosis with unsatisfactory response to these first line treatments.
- Prospective, multicentre, randomised, open-label, active-controlled, parallel groups, phase 2b/3 study to compare efficacy and safety of masitinib at 3 mg/kg/day with switch to 4.5 then 6 mg/kg/day as single agent first line treatment.;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Belgium, Brazil, Bulgaria, Canada, Colombia, Germany, Greece, Italy, Mexico, Slovakia, Spain, Switzerland, United Kingdom
- 2015-04-09
Not recruiting
- Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1
- Neurofibromatosis 1;Cutaneous Neurofibroma;Neurofibromatosis 1;Cutaneous Neurofibroma;Neurofibromatosis 1;Cutaneous Neurofibroma;Neurofibromatosis 1;Cutaneous Neurofibroma
- Brazil
- 2017-03-08
Not recruiting
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Belgium, Brazil, Canada, Croatia, Czech Republic, India, Israel, Macedonia, The Former Yugoslav Republic of, Poland, Russian Federation, Serbia, Slovenia, South Africa, Spain, United States
- 2013-04-16
Not Recruiting
- Study to compare the efficacy and/or safety of masitinib to interferon beta-1a, interferon beta-1b, peginterferon beta-1a or glatiramer acetate in patients with relapsing remitting multiple sclerosis with unsatisfactory response to these first line treatments.
- Relapsing-remitting multiple sclerosis (RR MS) MedDRA version: 18.0 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Belgium, Brazil, Bulgaria, Czech Republic, Germany, Greece, Hungary, Italy, Mexico, Slovakia, Spain, United Kingdom
- 2015-08-06
Not recruiting
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
- HIV Infections;Herpes Simplex;Sexually Transmitted Diseases
- Peru
- 2007-04-23
Not Recruiting
- Evaluation of a Diabetes Education Program in the clinical evolution of patients with type 1 diabetes mellitus treated at two public services in Brazil
- Type 1 Diabetes mellitus br>E10 M01.060.406 M01.060.057;E00-E90;M01.060.406;M01.060.057
- Brazil
- 2018-08-27
Not recruiting
- Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)
- Small Cell Lung Cancer
- Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-02-20
Not recruiting
- Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)
- Solid Tumor
- Australia, Austria, Brazil, Bulgaria, Croatia, Czechia, Denmark, Finland, France, Greece, Korea, Republic of, Netherlands, Norway, Philippines, Poland, Romania, Russian Federation, Singapore, Spain, Taiwan, Ukraine, United Kingdom, United States
- 2019-02-04
Not recruiting
- Human Insulin NPH and Insulin Aspart in Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1
- Argentina
- 2008-01-09